Recent Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment
Cancers · 01.03.2024 · 16 (5) · 1028
DOI: 10.3390/cancers16051028 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 01.03.2024. Verfasst von Holly Baker-Rand und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Cancer Grand Challenges.
Abstract (Originalsprache)
Endometrial cancer is the sixth commonest cancer in women worldwide, with over 417,000 diagnoses in 2020. The disease incidence has increased by 132% over the last 30 years and is set to continue to rise in response to an ageing population and increasing global rates of obesity and diabetes. A greater understanding of the mechanisms driving endometrial carcinogenesis has led to the identification of potential strategies for primary disease prevention, although prospective evaluation of their efficacy within clinical trials is still awaited. The early diagnosis of endometrial cancer is associated with improved survival, but has historically relied on invasive endometrial sampling. New, minimally invasive tests using protein and DNA biomarkers and cytology have the potential to transform diagnostic pathways and to allow for the surveillance of high-risk populations. The molecular classification of endometrial cancers has been shown to not only have a prognostic impact, but also to have therapeutic value and is increasingly used to guide adjuvant treatment decisions. Advanced and recurrent disease management has also been revolutionised by increasing the use of debulking surgery and targeted treatments, particularly immunotherapy. This review summarises the recent advances in the prevention, diagnosis and treatment of endometrial cancer and seeks to identify areas for future research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.
- Manchester Academic Health Science Centre, Department of Obstetrics and Gynaecology, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.
ORCID-Profile: Sarah J Kitson
Förderung
- Cancer Research UK
- Cancer Grand Challenges
Zitieren
APA
Baker-Rand, H., & Kitson, S. J. (2024). Recent Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment. Cancers, 16(5), 1028. https://doi.org/10.3390/cancers16051028
Vancouver
Baker-Rand H, Kitson SJ. Recent Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment. Cancers. 2024;16(5):1028. doi:10.3390/cancers16051028
BibTeX
@article{BakerRand2024,
author = {Baker-Rand, Holly and Kitson, Sarah J},
title = {Recent Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment},
journal = {Cancers},
year = {2024},
volume = {16},
number = {5},
pages = {1028},
doi = {10.3390/cancers16051028}
}
EUVIMED